Core Scientific, Inc.'s (CORZ) CEO Mike Levitt on Q4 2021 Results - Earnings Call Transcript

Mar. 29, 2022 6:54 PM ETCore Scientific, Inc. (CORZQ), CRZWQ
SA Transcripts profile picture
SA Transcripts
135.65K Followers

Core Scientific, Inc. (CORZ) Q4 2021 Earnings Conference Call March 29, 2022 4:30 PM ET

Company Participants

Steven Gitlin - Senior Vice President Investor Relations

Mike Levitt - Co-Founder, Co-Chairman, and Chief Executive Officer

Michael Trzupek - Chief Financial Officer

Conference Call Participants

Chris Brendler - D.A. Davidson & Co.

Gregory Lewis - BTIG

Joseph Vafi - Canaccord Genuity

Austin Vetterick - ROTH Capital Partners

Lucas Pipes - B. Riley Securities

Steven Gitlin

Good afternoon, ladies and gentlemen, and welcome to Core Scientific’s Full Fiscal Year 2021 Earnings Call. This is Steven Gitlin, Senior Vice President of Investor Relations for Core Scientific. At this time, all participants are in a listen-only mode. We will conduct a question-and-answer session after management’s remarks. As a reminder, this conference is being recorded for replay purposes.

Before we begin, please note that on this call certain information presented contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include without limitation, any statement that may predict forecast, indicate or imply future results, performance or achievements, and may contain words such as believe, anticipate, expect, estimates, intend, project, plan, or words or phrases with similar meaning.

Forward-looking statements are based on current expectations, forecasts and assumptions that involve risks and uncertainties, including but not limited to, economic, competitive, governmental and technological factors outside of our control that may cause our business strategy or actual results to differ materially from the forward-looking statements.

For further information on these risks, we encourage you to review the risk factors discussed in Core Scientific’s definitive proxy statement filed with the SEC on January 3, 2022, and other subsequent filings we filed with the SEC from time to time, including our annual report on Form 10-K for the year ended December 31, 2021 and our current report on

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.